← All companies

VNRX

VolitionRx Limited

VNRX NYSE In Vitro & In Vivo Diagnostic Substances EDGAR ↗

$0.50

+0.16 +47.35%

Key statistics

from XBRL data in SEC filings

Market cap ⓘ

$6.84M

Revenue (TTM) ⓘ

$2.46M

Net income (TTM) ⓘ

-$25.6M

EPS (TTM) ⓘ

$-3.09

P/E ratio ⓘ

—

Dividend yield ⓘ

—

Free cash flow ⓘ

-$19.8M

Cash ⓘ

$2.80M

Total assets ⓘ

$8.30M

Gross margin ⓘ

—

52-week range ⓘ

$0.33 – $14.80

Recent SEC filings

40 most recent

Annual, quarterly & current reports

8-K Unregistered sale of equity Aug 24, 2026

10-Q Quarter ended 2026-06-30 Aug 13, 2026

8-K Results of operations (earnings release) Aug 13, 2026

8-K Unregistered sale of equity Aug 7, 2026

8-K Amended charter or bylaws; Shareholder vote results Jul 21, 2026

8-K Unregistered sale of equity Jun 18, 2026

8-K Entered a material agreement; Other events Jun 10, 2026

8-K Entered a material agreement May 22, 2026

8-K Director or officer change May 15, 2026

10-Q Quarter ended 2026-03-31 May 14, 2026

8-K Results of operations (earnings release) May 14, 2026

10-K/A Fiscal year ended 2025-12-31 Apr 30, 2026

8-K Modified rights of security holders; Amended charter or bylaws Apr 28, 2026

8-K Delisting notice or listing-rule failure; Other events Apr 23, 2026

8-K Other events Apr 17, 2026

8-K Shareholder vote results Apr 1, 2026

10-K Fiscal year ended 2025-12-31 Mar 31, 2026

8-K Results of operations (earnings release) Mar 31, 2026

8-K Unregistered sale of equity Feb 20, 2026

8-K Delisting notice or listing-rule failure; Other events Feb 9, 2026

8-K Entered a material agreement; Unregistered sale of equity Jan 8, 2026

8-K Director or officer change Dec 11, 2025

10-Q Quarter ended 2025-09-30 Nov 13, 2025

8-K Results of operations (earnings release) Nov 13, 2025

8-K/A Entered a material agreement Nov 13, 2025

8-K/A Entered a material agreement Nov 10, 2025

8-K Entered a material agreement Nov 7, 2025

8-K Entered a material agreement; Results of operations (earnings release); Regulation FD disclosure Oct 14, 2025

10-Q/A Quarter ended 2025-06-30 Aug 15, 2025

10-Q Quarter ended 2025-06-30 Aug 14, 2025

8-K Results of operations (earnings release) Aug 14, 2025

8-K Entered a material agreement; Other events Aug 4, 2025

8-K Amended charter or bylaws; Shareholder vote results Jun 20, 2025

10-Q Quarter ended 2025-03-31 May 15, 2025

8-K Results of operations (earnings release) May 15, 2025

8-K Entered a material agreement; Terminated a material agreement Apr 22, 2025

8-K Regulation FD disclosure Apr 4, 2025

10-K Fiscal year ended 2024-12-31 Mar 31, 2025

8-K Results of operations (earnings release) Mar 31, 2025

8-K Entered a material agreement; Other events Mar 26, 2025